Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and 1,2,4-triazole

quinoxalines has been researched along with 1,2,4-triazole in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Aggarwal, R; Kumar, V; Mittal, A; Sumran, G1
Ali, I; Choi, G; Go, A; Lee, J; Lee, K1
Barakat, A; Boraei, ATA; Sarhan, AAM; Yousuf, S1
Kaneko, D; Koketsu, M; Ninomiya, M; Nishina, A; Ono, Y; Sonawane, AD; Tanaka, K; Yoshikawa, R1
Alanazi, MM; Alanazi, WA; Alasmari, A; Albassam, H; Alsaif, NA; Dahab, MA; Mahdy, HA; Obaidullah, AJ; Taghour, MS1

Other Studies

5 other study(ies) available for quinoxalines and 1,2,4-triazole

ArticleYear
Copper(II) chloride mediated synthesis and DNA photocleavage activity of 1-aryl/heteroaryl-4-substituted-1,2,4-triazolo[4,3-a]quinoxalines.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:12

    Topics: Copper; Cyclization; DNA Cleavage; DNA, Superhelical; Oxidation-Reduction; Photolysis; Plasmids; Quinoxalines; Triazoles; Ultraviolet Rays

2011
Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.
    Bioorganic & medicinal chemistry letters, 2017, 10-15, Volume: 27, Issue:20

    Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Evaluation, Preclinical; Half-Life; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Neoplasms; Nuclear Proteins; Protein Structure, Tertiary; Proto-Oncogene Proteins c-myc; Quinoxalines; Rats; Structure-Activity Relationship; Triazoles

2017
Synthesis of a New Series of Nitrogen/Sulfur Heterocycles by Linking Four Rings: Indole; 1,2,4-Triazole; Pyridazine; and Quinoxaline.
    Molecules (Basel, Switzerland), 2020, Jan-21, Volume: 25, Issue:3

    Topics: Carbon-13 Magnetic Resonance Spectroscopy; Heterocyclic Compounds; Hydrogen Bonding; Indoles; Molecular Conformation; Nitrogen; Proton Magnetic Resonance Spectroscopy; Pyridazines; Quinoxalines; Sulfur; Triazoles; X-Ray Diffraction

2020
Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
    Bioorganic chemistry, 2020, Volume: 104

    Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Oxadiazoles; Quinoxalines; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured

2020
Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies.
    Bioorganic & medicinal chemistry, 2021, 09-15, Volume: 46

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Protein Kinase Inhibitors; Quinoxalines; Structure-Activity Relationship; Triazoles; Vascular Endothelial Growth Factor Receptor-2

2021